Person:
GÜRSU, MELTEM

Loading...
Profile Picture
Google ScholarScopusORCIDPublons
Status
Organizational Units
Organizational Unit
Job Title
First Name
MELTEM
Last Name
GÜRSU
Name
Email Address
Birth Date

Search Results

Now showing 1 - 2 of 2
  • PublicationMetadata only
    COVID-19 Infection in Peritoneal Dialysis Patients: A Comparative Outcome Study with Patients on Hemodialysis and Patients without Kidney Disease
    (2022-01-01T00:00:00Z) KAZANCIOĞLU, Rümeyza; Ozturk, Savas; TURGUTALP, KENAN; GÜRSU, Meltem; ARICI, MUSTAFA; ORUÇ, AYŞEGÜL; Ahbap, Elbis; GÖKÇAY BEK, SİBEL; Sengul, Erkan; Ogutmen, Melike Betul; Genek, Dilek Gibyeli; Ayli, Mehmet Deniz; Ayar, Yavuz; Onan, Engin; Karadag, Serhat; AŞICIOĞLU, EBRU; Yazici, Halil; ALTIPARMAK, MEHMET RIZA; TOKGÖZ, BÜLENT; Odabas, Ali Riza; TONBUL, HALİL ZEKİ; Sezer, Siren; Yildiz, Alaattin; ATEŞ, KENAN; KAZANCIOĞLU, RÜMEYZA; GÜRSU, MELTEM
    Objectives: There is limited data about coronavirus disease-19 (COVID-19) characteristics and results in peritoneal dialysis (PD) patients. This study aimed to investigate the characteristics and outcomes among PD patients and compare them with matched hemodialysis (HD) patients and a control group without kidney disease. Methods: We included 18 PD patients and consecutive age- and gender-matched 18 HD and 18 patients without kidney disease (control group) registered into the Turkish Society of Nephrology database including 1301 COVID-19 patients. We compared demographic, clinical, radiological, laboratory data, and outcomes namely intensive care unit (ICU) admission, mechanical ventilation, mortality, and composite outcome (death and/or ICU admission). Results: ICU admission, mechanical ventilation, and mortality rates in PD patients (27.8%, 22.2%, and 22.2%, respectively) and the HD group (16.7%, 11.1%, and 16.7%, respectively) were higher than the control group (11.1%, 11.1%, and 5.6%, respectively), but intergroup comparison did not reveal difference. A total of 11 (20.3%) patients had composite outcome (6 PD patients, 3 HD patients, and 2 patients in the control group). In Cox regression analysis, higher age and higher CRP level were related to increased risk of composite outcome. Adjusted rate of composite outcome in PD group was significantly higher than the control group (P =.050). This rate was similar in HD and control groups (P =.30). Conclusions: Combined in-hospital mortality and/or ICU admission of PD patients with COVID-19 was significantly higher than the control patients. There is a need for careful surveillance of PD patients for infection signs and prompt treatment of COVID-19.
  • PublicationOpen Access
    Extreme Hyperkalemia in a Hemodialysis Patient Presenting with Cardiac Arrhythmia
    (2019-10-01) ARTAN, AYŞE SERRA; GÜRSU, Meltem; ELÇİOĞLU, Ömer Celal; Deligoz Bildaci, Yelda; KAZANCIOĞLU, RÜMEYZA; ARTAN, AYŞE SERRA; GÜRSU, MELTEM; ELÇİOĞLU, ÖMER CELAL; DELİGÖZ BİLDACI, YELDA; KAZANCIOĞLU, RÜMEYZA
    Hyperkalemia is commonly seen in hemodialysis patients and is a potentially life-threatening condition. Serum potassium concentration greater than 10 mEq/L is defined as extreme hyperkalemia. Emergent treatment of hyperkalemia is made with intravenous calcium, insulin-dextrose solutions, diuretics, gastrointestinal cation-exchange resin and dialysis. We present here a 52-year-old chronic hemodialysis patient with extreme hyperkalemia and cardiac arrhythmia. She was treated with emergent hemodialysis. Her abnormal laboratory findings and electrocardiography recovered. Further examinations suggested insufficient hemodialysis treatment as the possible cause of hyperkalemia.